RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+17.9%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.07B
AUM Growth
+$1.07B
(+25%)
Cap. Flow
+$126M
Cap. Flow
% of AUM
11.81%
Top 10 Holdings %
Top 10 Hldgs %
29.29%
Holding
121
New
28
Increased
49
Reduced
15
Closed
16
Top Buys
| 1 |
Pfizer
PFE
|
$26.4M |
| 2 |
Bausch Health
BHC
|
$18.2M |
| 3 |
Travere Therapeutics
TVTX
|
$16.8M |
| 4 |
Eli Lilly
LLY
|
$16.7M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$16.5M |
Top Sells
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$30.2M |
| 2 |
Merck
MRK
|
$25.6M |
| 3 |
STJ
St Jude Medical
STJ
|
$21.8M |
| 4 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$18.6M |
| 5 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$10.3M |
Sector Composition
| 1 | Healthcare | 75.22% |
| 2 | Financials | 1.56% |
| 3 | Industrials | 0.97% |
| 4 | Technology | 0.96% |
